Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan.

MLA

Wake, Mayumi, et al. “Adherence and Persistence to Hyperlipidemia Medications in Patients with Atherosclerotic Cardiovascular Disease and Those with Diabetes Mellitus Based on Administrative Claims Data in Japan.” Atherosclerosis (00219150), vol. 282, Mar. 2019, pp. 19–28. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2018.12.026.

APA

Wake, M., Oh, A., Onishi, Y., Guelfucci, F., Shimasaki, Y., & Teramoto, T. (2019). Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan. Atherosclerosis (00219150), 282, 19–28. https://doi.org/10.1016/j.atherosclerosis.2018.12.026

Chicago

Wake, Mayumi, Akinori Oh, Yoshie Onishi, Florent Guelfucci, Yukio Shimasaki, and Tamio Teramoto. 2019. “Adherence and Persistence to Hyperlipidemia Medications in Patients with Atherosclerotic Cardiovascular Disease and Those with Diabetes Mellitus Based on Administrative Claims Data in Japan.” Atherosclerosis (00219150) 282 (March): 19–28. doi:10.1016/j.atherosclerosis.2018.12.026.